Tuesday, August 26, 2025 1:22:48 PM
Nothing is "Really Simple" when you are CEO of a small company that developed a breakthrough, immunotherapeutic technology that is and will continue to change the landscape of healthcare treatments forever for the better, much the same way that Apple changed the world of communications and every aspect of every supporting company making all things better. Every company that touches communications has to become "A Part Of" or risk failure. That's what biotech companies realized after Dr. Marnix Bosch's June 3rd, 2023 ASCO presentation. So Linda Powers' challenge was to learn how to protect and commercialize the technology before other biotech giants destroyed little NWBO and seized the technology.
First step was patent coverage and second step was build a manufacturing capability to produce the dendritic cell immunotherapy treatment and deliver it to patients worldwide. Nothing simple about that, but Linda Powers designed and implemented a strategy to do just that. Visionary thinkers are way past personal enrichment in their efforts to make a difference to the whole of humankind!!! False pride, arrogance, and greed are many of the character defects that result from envy and jealousy that are very apparent in those who always look for a reason to discredit those who, through their actions, force others among us to recognize our shortcomings and change our thoughts and actions to that which help others in need. That is what Linda Powers and other visionaries are fighting every minute of their life. That's the age-old battle of the "Haves vs The Have Nots" !!!! Well, in the caser of NWBO and Linda Powers, it's much more than "The Haves vs The Have Nots", it's the Patients In Need" being championed by NWBO in providing treatments that will save lives and reduce fear and pain, which I believe are the most destructive elements to the world we live in !!! So, I'm asking you to disregard the petty claims of posters who are suggesting that visionaries, driven by the desire to help humankind, are somehow motivated by the same greed that encourages these posters to write these comments in an effort to promote Fear, Uncertainty and Despair.
Cheers, BB
First step was patent coverage and second step was build a manufacturing capability to produce the dendritic cell immunotherapy treatment and deliver it to patients worldwide. Nothing simple about that, but Linda Powers designed and implemented a strategy to do just that. Visionary thinkers are way past personal enrichment in their efforts to make a difference to the whole of humankind!!! False pride, arrogance, and greed are many of the character defects that result from envy and jealousy that are very apparent in those who always look for a reason to discredit those who, through their actions, force others among us to recognize our shortcomings and change our thoughts and actions to that which help others in need. That is what Linda Powers and other visionaries are fighting every minute of their life. That's the age-old battle of the "Haves vs The Have Nots" !!!! Well, in the caser of NWBO and Linda Powers, it's much more than "The Haves vs The Have Nots", it's the Patients In Need" being championed by NWBO in providing treatments that will save lives and reduce fear and pain, which I believe are the most destructive elements to the world we live in !!! So, I'm asking you to disregard the petty claims of posters who are suggesting that visionaries, driven by the desire to help humankind, are somehow motivated by the same greed that encourages these posters to write these comments in an effort to promote Fear, Uncertainty and Despair.
Cheers, BB
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
